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Abstract Sixty-four children, aged 7 to 14 years, with
early-treated PKU, were compared with control children on
visual evoked potential (VEP) amplitudes and latencies and
auditory mismatch negativity (MMN) amplitudes. It was
further investigated whether indices of dietary control
would be associated with these evoked potentials parame-
ters. There were no significant differences between controls
and children with PKU in VEP- and MMN-indices.
However, higher lifetime Phe levels were, in varying
degree and stronger than concurrent Phe level, related to
increased N75 amplitudes, suggesting abnormalities in
attention, and longer P110 latencies, indicating a reduction
in speed of neural processing, possibly due to deficits in
myelination or reduced dopamine levels in brain and retina.
Similarly, higher lifetime Phe levels and Index of Dietary
Control (IDC) were associated with decreased MMN
amplitudes, suggesting a reduced ability to respond to
stimulus change and poorer triggering of the frontally
mediated attention switch. In summary, the present study in
children with PKU investigated bottom-up information
processing, i.e., triggered by external events, a fundamental
prerequisite for the individual’s responsiveness to the
outside world. Results provide evidence that quality of
dietary control may affect the optimal development of these
pre-attentive processes, and suggest the existence of
windows of vulnerability to Phe exposure.
Keywords Phenylketonuria.ERP.VEP.MMN.dietary
control.lifetime Phe.pre-attentive processing.attention
List of abbreviations
AEP Auditory evoked potential
AOT Auditory oddball task
CRT Checkerboard reversal task
EEG Electroencephalogram
EOG Electro occulogram
ERP Event-related potential
IDC Index of dietary control
MMN Mismatch negativity
Phe Phenylalanine
PKU Phenylketonuria
RT Reaction time
Tyr Tyrosine
VEP Visual evoked potential
Phenylketonuria (PKU; OMIM 261600 and 261630)) is an
inherited metabolic disease that affects the metabolism of
the amino acid phenylalanine (Phe). If left untreated, blood
Phe levels increase and children with PKU may develop
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DOI 10.1007/s10545-011-9321-9severe mental retardation, due to the effects of high cerebral
concentrations of Phe and/or lower concentrations of other
large neutral amino acids, resulting in poor myelination of
neuronal connections and decreased concentration of the
neurotransmitters dopamine and serotonin (Scriver et al.
1995; Van Spronsen et al. 2009). Since the discovery of
effective dietary treatment (Bickel et al. 1953), prevention
of mental retardation has been accomplished by early
screening and the use of a low Phe diet. Although
intellectual development of early-treated children with
PKU is close to normal (Burgard 2000), quality of dietary
treatment is critical as it has been shown that concurrent
and lifetime Phe levels are negatively related to different
aspects of cognitive functioning, such as executive func-
tioning (Azadi et al. 2009; Christ et al. 2010; DeRoche and
Welsh 2008; VanZutphen et al. 2007), sustained attention
(Schmidt et al. 1994; Huijbregts et al. 2002a), and speed of
processing (Albrecht et al. 2008).
Compromised myelination of neuronal connections,
particularly in the first months of gestation, and deficient
levels of dopamine and serotonin may affect the develop-
ment of prefrontal cortical functions in particular (Leuzzi et
al. 2000; Diamond 2001). A number of studies using
magnetic resonance imaging (MRI) and/or Diffusion Tensor
Imaging (DTI) indeed have shown abnormalities in the
microstructural integrity of the white matter in early-treated
PKU patients (Dyer 1999; Cleary et al. 1994; Thompson et
al. 1993; Weglage et al. 1997), even in normal appearing
white matter (Ding et al. 2008; Kono et al. 2005; Leuzzi et
al. 2007; Vermathen et al. 2007; Manara et al. 2009;
Scarabino et al. 2009; White et al. 2009).
Despite the evidence for (minor) structural brain deficits
in PKU patients and the subtle brain dysfunctions inferred
from neuropsychological assessments, more direct evidence
for functional disturbances in brain areas involved in
attention and information processing is scarce or inconsis-
tent. The present study focuses on two neurophysiological
markers of visual and auditory information processing: the
visual evoked potential (VEP) elicited by the checkerboard
reversal paradigm and the auditory mismatch negativity
(MMN) elicited by an auditory oddball paradigm.
The VEP is considered to provide important information
about the functional integrity of the visual system (Odom et
al. 2004). The early components of the VEP to pattern
reversal gratings consist of a negative peak around 75 ms
(N75), originating from the primary visual cortex (area V1),
and a positive peak around 100–110 ms (P100). The P100
is also generated in area V1, although some researchers
suggest the extrastriate visual area to be a more likely
candidate (Di Russo et al. 2005). Studies of pattern reversal
VEPs have shown a low variability of wave form and rapid
decrease in P100 latency over the first postnatal year, and
VEP maturation is rapid in infants, gradual in preschool
years, and persists until adulthood (Lenassi et al. 2008;
Lippé et al. 2009).
Since its discovery (Näätänen et al. 1978), auditory
mismatch negativity (MMN) has been linked with two
important concepts of experimental psychology: memory
and attention. MMN is elicited by a discriminable change in
auditory stimulation (Näätänen et al. 2007). The MMN
reflects an automatic process triggered by a difference
between an incoming stimulus and a sensory memory trace
of preceding stimuli (memory-trace hypothesis) or is
thought to be generated by any irregularity that violates a
pattern encoded in the auditory system (predictive models,
see review by Winkler 2007). MMN is generated from
auditory cortices bilaterally, possibly with an additional
downstream component in the frontal cortex. The frontal
MMN reflects the activation of the cortical mechanism
implicated in the recruitment of attention (involuntary
attention switching) (Duncan et al. 2009). To date, attempts
to elucidate the role of dopaminergic and serotonergic
systems on MMN have provided inconsistent results
(Leung et al. 2010).
VEP latency has been shown to be longer in children with
PKU than in controls (Korinthenberg et al. 1988;L u d o l p he t
al. 1996; Leuzzi et al. 1998; Henderson et al. 2000; Koletzko
et al. 2009) and was found to be correlated with diet
compliance (Giovannini et al. 1988; Korinthenberg et al.
1988;L e u z z ie ta l .1998), but other studies found no
relationship (e.g., Pietz et al. 1993; Jones et al. 1995,i n
older patients). Auditory evoked potential activity has
seldomly been investigated in PKU. Some studies report
delayed potentials (Cardona et al. 1991;C o s k u ne ta l .1993)
while others do not (e.g. Ludolph et al. 1996).
In summary, the present study investigated bottom-up
information processing, i.e., triggered by external events
(vs. top-down control processes), a fundamental prerequi-
site for the individual’s responsiveness to the outside world.
Amplitude and latency of event-related potential (ERP)
correlates of these automatic pre-attentive processes are
thought to be affected by alterations in neuronal myelina-
tion and neurotransmitter concentrations. The goal of the
present study was twofold. First, we investigated whether
children with PKU differed from age-matched controls in
terms of patterns of early and late ERPs elicited in response
to visual and auditory stimulation. Based on evidence for
both sensory and attentional deficits, it was predicted that,
in comparison with healthy controls, children with PKU
would show prolongation of latencies and reduction in
amplitudes of ERP-waves associated with these processes.
Second, we examined whether differences in long-term
dietary control were related to differences in brain activity.
It was predicted that indices of dietary control and
concurrent Phe levels would be correlated with latencies
and amplitudes of early as well as late potentials.
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The study was approved by the medical ethical commit-
tees of all participating treatment centers as well as by
the Dutch National PKU Steering Committee. Written
informed consent was obtained from patients’ parents or
caretakers.
Subjects
Sixty-seven children with PKU, sampled from the Dutch
population of patients between 7 and 14 years of age (n=85),
participated in a national study on PKU (Huijbregts et al.
2002b). After data cleaning, the PKU group comprised 64
children (55% female) with complete data with a mean age
of 10.9 (SD=2.2) years. All diagnoses were made within the
first two weeks after birth and all children with PKU were
treated early (<1 month after birth) and continuously with
dietary restrictions to limit Phe intake, and their Phe levels
were monitored regularly. Blood samples were taken on the
day of testing to determine concurrent Phe levels (M=
481 μmol/L, SD=258). Historical Phe levels were
collected by the pediatricians with the help of TNO
Prevention and Health in Leiden, The Netherlands. To
study the effects of higher versus lower concurrent Phe
levels, 37 children with PKU were allocated to a high
Phe group (PKU-H; Phe >360 μmol/L; M=632, SD=
191), and 27 children were allocated to a low Phe group
(PKU-L; Phe≤360 μmol/L; M=226, SD=101). These
criteria were based on treatment recommendations pro-
vided by the NIH Consensus Statement Panel (2000).
Mean age of the PKU-L group was 10.98 years (SD 2.3)
which did not significantly differ (p=.88) from the mean
age of the PKU-H group of 10.90 years (SD 2.1).
The Index of Dietary Control (IDC) was computed as the
mean of all half-year median blood Phe levels during the
lifetime (M=334 μmol/L, SD=111). Mean IDC for the
PKU-H group was 363 μmol/L (SD=130), and for the
PKU-L group mean IDC was 295 μmol/L (SD=57). IDC
was significantly related to concurrent Phe level (r=.53,
p<.001). IDC was also significantly related to all yearly
Phe-means (correlations ranging from r=.48 (p<.001; 1st
year of life) to r=.88 (p<.001; 7th year of life). The
correlations between IDC and Phe level during the first
month of life (when levels are stabilized) was weaker, but
still significant (r=.34, p=.005). Although overall, there
was a significant correlation between concurrent Phe level
and IDC, concurrent Phe level was not significantly related
to mean Phe level during the first month of life, or the mean
Phe levels during the 1st, 4th, and 5th years of life. Similar
patterns of correlations were observed for the PKU-L and
the PKU-H groups, with significant associations between
IDC and Phe levels in different years (and during the first
month of life), significant associations between IDC and
concurrent Phe level, but no (or much weaker) relations
between concurrent Phe levels and Phe levels in different
years (and during the first month of life).
These descriptive statistics indicate that concurrent and
lifetime Phe levels can be treated as separate (independent)
predictors for the association with electrocortical activity.
Further, predictions from different indices of dietary control
throughout life may be theoretically informative since it is
hypothesized that similar Phe levels may have a differential
impact at different stages in life.
Seventy-three healthy children, aged 7–14 years, were
recruited from the patients’ families or peer groups or
through newspaper advertisements to serve as a control
group. After data cleaning, the control group comprised 69
children (42% female) with complete data, with a mean age
of 10.9 (SD=2.3) years.
Tasks and stimulus material
The checkerboard reversal task (CRT) was used to measure
VEPs and consisted of the presentation of two blocks of 71
trials each. Each trial consisted of the presentation of a
white and black checkerboard pattern for the duration of
400 ms at the center of a computer monitor. On the next
trial a reversed checkerboard pattern was presented and so
on. The checkerboard pattern was made up of 49 black and
white checkers. Checker size was 1.65 degrees and the total
display subtended 10.8 degrees. Participants were
instructed to attend to the center of the computer screen
during the series of trials presented and to refrain from eye
blinking as much as possible.
The auditory oddball task (AOT) was used to measure
auditory evoked potentials (AEP), and consisted of the
presentation of series of frequent standard tones with
irregular presentations of infrequent deviant tones. Nine
hundred tone-trials (three blocks of 300 tone-trials each)
were presented with 780 trials (87%) consisting of
standard tones (1000 Hz), 60 trials (6.5%) were low
deviant tones (900 Hz), and 60 trials (6.5%) were high
deviant tones (1100 Hz). The tones were presented in a
pseudo-random order with at least three and maximally
nine standard tones in between two deviant tones.
Stimulus duration was 50 ms (5 ms fade-in/fade-out)
and the interstimulus interval was 600 ms, resulting into
a frequency of 1.66 trials per second. Stimulus tones
were presented binaurally through headphones while the
participant’s attention was engaged by reading a comic
book. The children were instructed to pay attention only
to their comic book and to discard the tones presented
through the headphones.
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During both tasks EEG was recorded continuously from 33
AgAgCL electrodes, placed according to the 10/20 inter-
national electrode placement system (see Fig. 1), mounted
in an electrode cap (ESI Electro Cap Inc). Vertical (VEOG)
and horizontal (HEOG) eye movements were recorded
using electrodes above and below the right eye and
electrodes placed on the outer canthi of both eyes,
respectively. A ground electrode was placed on the
forehead and linked ear lobes were used a reference.
Impedance of all electrodes was kept below 5 kΩ.
Both EEG and EOG were pre-amplified and digitized by
a portable 40 channel Twente Medical System recorder
(REFA-40/DC), controlled by Poly software (Poly 4.9;
Inspektor Research Systems, 1993). The time constant was
set to 5 s and the low pass filter was set at 35 Hz. EEG and
EOG were sampled with a frequency of 200 Hz. Stimulus
presentation, timing and data logging were software-
controlled (ERTS 3.18, Beringer 1996).
The experiments were performed on location in the
different treatment centers that participated in the study.
Prior to the beginning of the EEG recordings blood samples
were taken for Phe analyses. Subsequently, participants
were administered a visual acuity test (Landholt ogenkaart,
TNO Soesterberg, The Netherlands) and a hearing test
(detection of 500 Hz, 1000 Hz and 2000 Hz probes) to
detect gross visual and/or auditory deficits. The CRT was
always administered first followed by the 3 blocks of the
AOT that were counterbalanced across subjects.
Data reduction
The recorded continuous EEG files were analyzed using
SCAN 4.2 (Neurosoft, Inc). In both tasks, EEG files were
first corrected for the effects of eye-blinks using SCAN 4.2
ocular artefact correction procedures. Subsequently, the
EEG files were epoched. In the checkerboard reversal task
epoch length was 340 ms including a 50 ms pre-stimulus
period, whereas in the auditory oddball task epoch length
was 640 ms and included a 100 ms pre-stimulus period. In
the next step EEG epochs were base-line corrected and
trials with EEG artefacts (signals passing±100 μV) were
removed. Finally, EEG and EOG signals were averaged
across epochs separately for each channel and condition. In
the checkerboard reversal task, average VEPs were
obtained across the two blocks, whereas in the auditory
oddball task average auditory evoked potentials were
obtained across the three trial blocks separately for standard
tones that preceded deviant tones (ST), and for the high
(HD) and low deviant (LD) tones. Finally, the average pre-
(Pre)frontal electrode sites
Auditory Oddball Task 
Occipital electrode sites 
Checkerbord Reversal task
Fig. 1 The 10/20 international electrode placement system. The used
electrode sites are indicated by bold circles for the Auditory oddball
task (upper half) and the checker board reversal task (bottom). Each
electrode position is characterized by one or more letters to identify
the underlying brain area and a number or letter to identify the
hemisphere (even number: right hemisphere, odd number: left
hemisphere, letter z: midline). The letters F, C, T, P and O stand for
frontal, central, temporal, parietal and occipital. The letters FP refer to
a prefrontal electrode (frontopolar). Electrodes anterior to the frontal
electrodes are named anterior frontal (AF). Electrodes positioned
between frontal and central electrodes, central and parietal electrodes,
parietal and occipital electrodes, parietal and temporal electrodes and
frontal and temporal electrodes are labeled FC (frontocentral), CP
(centroparietal), PO (parieto-occipital), TP (parietotemporal) and FT
(frontotemporal) respectively
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average event related potentials (ERPs), and ERP wave-
forms were smoothed using a digital filter. In the auditory
oddball task mismatch-related ERP waveforms (MMN)
were obtained by subtracting ST ERPs from HD and LD
ERPs.
To determine peak-values and latencies for both tasks,
grand-average ERPs were obtained by averaging ERPs
across subjects for each task separately for controls and
children with PKU. Average VEPs from the CRT and
average MMN waveforms in the AOT of the control sample
are depicted in Figs. 2 and 3, respectively. Visual inspection
of Fig. 2 shows that the VEP over occipital sites consists of
an early negative peak around 75 ms (N75), followed by a
positive peak around 110 ms (P110). N75 was defined as
the maximum negativity at O1, Oz and O2 electrodes in the
period from 50–100 ms, whereas P110 was defined as the
maximum positivity in the interval from 75–125 ms. In
addition to amplitudes, latencies of the different peaks were
also determined at the occipital electrodes (see Fig. 1).
Inspection of Fig. 3 shows that the MMN in the AOT is
characterized by maximal negativity at frontal sites around
190–200 ms. Due to considerable variance in MMN
latencies and subsequent difficulties in peak-scoring, only
MMN amplitudes were analyzed. For that purpose, average
MMN amplitudes were calculated in the epoch from 150–
250 ms at the (pre)frontal and central electrodes (see
Fig. 1).
Data analysis
N75, P110 and N170 amplitudes and latencies from the
CRT were analyzed using repeated measures analysis of
variance (ANOVA) with Group (control, PKU-L, PKU-H)
as between subjects factor and Hemisphere (O1 vs O2) as
within subjects factor. Amplitudes and latencies of the same
peaks at Oz were analyzed using a One Way ANOVA with
Group as between subjects factor. MMN amplitudes from
the AOT were analyzed employing repeated measures
ANOVA with Group as between subject factor and
Topography (outer lateral vs inner lateral sites) and
Hemisphere (left vs. right) as within subjects factors. For
all analyses involving factors with more than two levels
Greenhouse-Geisser corrected p-values will be reported to
prevent inflation of statistical significance.
Pearson product-moment correlations were computed
and regression analyses were performed to assess the
relationship between variance found in the total sample in
Phe levels (concurrent, lifetime and IDC) and the variances
in indices of brain activity. Life time Phe levels were the
median of Phe recordings for each year from 0 to 10 years
of age. The IDC was represented by the average median
Phe level across the first 10 years (or less if children were
younger). Age was always entered as the first variable in
these analyses. Regression results will be reported only if
standardized residuals were below three and Cook’s
distances were below one (Stevens 1996). Effect sizes were
estimated using partial eta squared (ηp
2), and interpreted as
small (ηp
2≈0.01), medium (ηp
2≈d 0.06), and large (ηp
2>
0.13) (Cohen 1988).
Results
Effects of changes in visual stimulation on VEP
Analyses of N75 and P110 amplitudes and latencies at O1
and O2, and at Oz respectively, did not reveal any
significant main effect or interaction, indicating that
controls and children with PKU, and children with PKU-L
and PKU-H, respectively, did not differ in occipital
amplitudes and latencies.
Significant correlations, however, were found be-
tween concurrent Phe levels and P110 latencies at O2
(r=.25, p=.023) and N170 latencies at Oz (r=.21,
ms -100.0 0.0 100.0 200.0 300.0 400.0 500.0
µV
0.0
-1.0
-2.0
-3.0
-4.0
1.0
2.0
3.0
4.0
MMN
Fig. 3 Averaged mismatch negativity (MMN) of control sample at the
midline frontal electrode site (Fz)
ms
-50.0 0.0 50.0 100.0 150.0 200.0 250.0
µV
0.0
-5.0
-10.0
5.0
10.0
N75
P110
Fig. 2 Averaged visual evoked potential of control sample at the
midline occipital electrode site (Oz). N75=maximum negative peak at
75 ms post stimulus onset. P110=maximum positive peak at 110 ms
post stimulus onset
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p=.038), indicating that latencies increase with increasing
Phe or IDC levels. The analyses of historical levels revealed
that P110 amplitude at O1 was associated with median Phe
levels at ages 2 and 4–7 years (r varies from .26 to .28,
p-values vary from .025 to .018, 1-tailed). At age 9, N75
amplitudes at O1, O2 and Oz correlated significantly with
Phe levels (r varies from -.33 to -.37, p-values vary from
.014 to .006, 1-tailed). N75 latencies at O1, O2, and Oz
correlated with Phe levels at age 4–7 years (r varies from -
.225 to -.33, p-values vary from .042 to .007, 1-tailed). In
sum, these correlations indicate that higher life time Phe
levels at younger ages were associated with larger P110
latencies and amplitudes, larger N75 amplitudes and
shorter N75 latencies.
Regression analyses with Phe levels as independent
variables and VEP latencies and amplitudes as dependent
variables (see Table 1) confirmed these findings. Variance
in concurrent Phe levels explained 4.8% of variance in
P110 latencies at O2. The analyses on lifetime data showed
that Phe levels at age 4, 5, and 6 years accounted for 11.9%,
25%, and 14.5% of variance, respectively, in P110
amplitudes at O1, O2, and Oz. In addition, Phe levels at
age 4 and 5 years accounted for 5.6% and 15.1% of
variance in N75 latencies respectively, whereas Phe levels
at age 9 years explained 11.7% of the variance in N75
amplitudes at O2.
Effects of changes in auditory stimulation (MMN)
Analyses of the MMN amplitudes at the selected lateral
frontal sites showed that MMN was larger at F3/F4 than at
F7/F8 (F(1,104)=9.488, p=.003, η
2=.084), and was larger
over the right than over the left hemisphere at frontal (F)
and fronto-central (FC) sites (F(1,104)=7.229, p=.008,
η
2=.065; F(1,105)=6.585, p=.012, η
2=.059). No signif-
icant Group effects or interactions involving Group were
found, indicating that controls and children with PKU, and
children with PKU-L and PKU-H, respectively, did not
differ in MMN latency and amplitude.
Multiple regression analyses on MMN amplitudes and
concurrent Phe levels and IDCs (see Table 2) revealed that
variance in IDC scores accounted for 8.1% of the variance
in MMN amplitudes elicited by low tone deviants, and for
52.2% of the variance in average MMN amplitudes (mean
of low deviant tone MMN and high deviant tone MMN) at
frontal sites. Variance in concurrent Phe levels explained
14.8% of variance in average MMN amplitudes at frontal
sites.
Correlations between Phe and IDC and MMN ampli-
tudes for low tone deviants and average MMN ampli-
tudes at AF8 and F4 ranged from .29 to .40 (p ranges
from .023 to .004, 1–tailed), indicating that increased Phe
or IDC scores were associated with reduced MMN
amplitudes.
More detailed stepwise regression analyses on lifetime
Phe levels showed that individual differences in Phe levels
in the first year of life accounted for 11.6% of the variance
in average MMN amplitudes, and for 33.3% of variance in
high tone MMN amplitudes at frontal and anterior-frontal
sites. MMN amplitudes elicited by low tone deviants
accounted for 12.1% of the variance in Phe levels at age
2 years. Further significant relationships were found
between Phe levels at age 8 years and high tone MMN
amplitudes at frontal sites (18.2% of variance explained)
and between Phe levels at age 9 years and high tone MMN
amplitudes at right frontal sites (39.1%), and low tone
MMN amplitudes at fronto-central midline sites (35.4%).
Zero-order correlations between lifetime Phe levels and
MMN amplitudes for significant regression effects ranged
from .30 to .52 (p-values ranged from .024 to .0001, 1-
tailed). All correlations indicate that increased Phe levels at
younger and older ages are associated with reduced MMN
amplitudes.
Table 1 Results of regression analyses on concurrent and lifetime Phe
measures and VEP amplitudes (amp) and latencies (lat). Regression
results are reported only if standardized residuals were below three
and Cook’s distances were below one and the regression model was
significant. R
2=portion of explained variance in the VEP components.
For example: Phe levels at the age of 5 accounted for 25% (.0252) of
the variance in P110 amplitude at the occipital sites
Phe measure VEP component Sites R
2 df F P
Conc. Phe P110 lat O2 .048 1/61 4.05 .049
Phe age 4 P110 amp O1, O2, Oz .119 2/51 4.44 .017
N75 lat O2 .056 1/51 4.04 .050
Phe age 5 P110 amp O1, O2, Oz .252 2/52 9.68 .001
N75 lat O1, O2, Oz .151 2/53 5.64 .006
Phe age 6 P110 amp O1, O2, Oz .145 2/53 5.51 .007
Phe age 9 N75 amp O2 .117 1/41 6.55 .014
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Pre-attentive visual processing
In contrast with the predictions, the differences in VEP and
MMN, between children with PKU and controls, and
between children with PKU-L and PKU-H, were not
significant. The results are in agreement with a study by
Jones et al. (1995) who reported pattern reversal VEP
latencies within the normal range for 8 out of 9 children,
but others found prolonged VEP latencies (Leuzzi et al.
1998). The comparison, however, is compromised as the
quality of dietary control in these two studies was less
optimal with mean concurrent Phe levels of 756 μmol/L
(SD=266), and 726 μmol/l (SD=378), respectively. More
recent studies, assessing well-controlled subjects with PKU,
with mean Phe levels≤360 μmol/L, demonstrated pro-
longed, less mature P100 latencies in infants (Agostoni et
al. 2006), and in young children with PKU (Beblo et al.
2001; Henderson et al. 2000; Koletzko et al. 2009)
compared to controls. In addition to differences in
methodology, a reason for the discrepancy in results might
lie in the age of assessment with the children of the
referenced study being much younger (6.3 years, SD=0.5)
than the children in the present study (10.9 years, SD=2.2).
A positive relationship between some VEP latency
measures and concurrent Phe levels was found at occipital
sites indicating that children with PKU with higher Phe
levels have longer VEP latencies. These findings confirm
other reports (Creel and Buehler 1982; Korinthenberg et al.
1988; Henderson et al. 2000), and may reflect a reduction
in speed of neural processing possibly due to subtle deficits
in myelination of connections in the visual system in
children with higher Phe levels (Hommes et al. 1982;
Thompson et al. 1990) or to reduced levels of dopamine in
the eye and the brain (Ullrich et al. 1996). In light of this
topic it is interesting to observe that individual differences
in lifetime Phe levels at age 4–6 years accounted for 11.7 to
25% of the variance in VEP P110 amplitudes and N75
latencies at later ages (see Table 1), which indicates more
explanatory power for Phe levels during specific periods of
life than for concurrent Phe levels. Long lasting effects of
first month Phe levels, ranging from 1050 – 1470 μmol/L,
on visual contrast sensitivity in children with PKU, with a
mean age 7.1 years (SD=1.1), have been reported by
Diamond and Herzberg (1996), suggesting some early
structural damage to the visual system, possibly due to
elevated Phe levels in the first post-natal weeks. In the
present study, post-natal Phe levels, measured within
2 weeks after birth were also highly elevated (about
1350 μmol/L) which might have interfered with a normal
development of the dopamine-sensitive visual system. We
did however not find significant predictions of VEP-
components from these early Phe levels. There was a
significant prediction from concurrent Phe, suggesting a
role for dopamine, but predictions from several lifetime
measures were generally stronger, which might suggest 1) a
weaker-than-expected role in this task for dopamine-
dependent visual information processing, and 2) a larger-
than-expected role for cortical structures (i.e., the occipital
lobe) in the type of visual bottom-up processing associated
with this task. Although neural proliferation ends at birth,
apoptosis continues well into the first years of life, and
synaptogenesis and myelination continue into adolescence
and adulthood, respectively (Tau and Peterson 2010).
Myelination and synaptic remodeling are particularly active
between the ages of 2 and 5, and cortical gray matter
continues to increase in volume through the ages of 4 or
5 years (Levitt 2003). Thus, it may be the case that
structural damage to cortical structures following prolonged
periods of elevated Phe may also affect pre-attentive visual
processing. Our data also appear to indicate that Phe levels
representative of dietary control throughout life (consider-
ing the high correlations between different indices) are
more harmful during specific critical periods in brain
development.
Pre-attentive auditory processing
The AOT showed the expected maximal distribution of
MMN over frontal sites with larger amplitudes over the
right than over the left hemisphere (Giard et al. 1990).
Phe measure MMN component Sites R
2 df F P
Conc.Phe MMN-av AF8, F8 .148 2/45 5.07 .010
IDC MMN-lt F .081 1/41 4.73 .036
ln(IDC) MMN-av AF3, AF4, Fpz, Fp2 .522 4/39 12.74 .0001
Phe age 1 MMN-av F, AF .116 1/41 6.53 .014
MMN-ht F, AF .333 2/40 11.50 .0001
Phe age 2 MMN-lt F, AF .121 1/40 6.67 .014
Phe age 8 MMN-ht FC6, FPz .182 2/38 5.47 .008
Phe age 9 MMN-ht F8, Fp2 .391 2/33 12.21 .0001
MMN-lt Cz, Fz, Fpz .354 3/32 7.39 .001
Table 2 Results of regression
analyses on concurrent and
lifetime Phe measures, IDC and
MMN amplitudes. lt=low tone
deviants, ht=high tone deviants,
av=average MMN amplitudes.
Regression results are reported
only if standardized residuals
were below 3 and Cook’s
distances were below 1 and the
regression model was
significant. R
2=portion of
explained variance in the
MMN components
J Inherit Metab Dis (2011) 34:953–962 959Although we predicted smaller MMN amplitudes for
children with PKU compared with normal controls, in
particular for children with PKU with high Phe levels, no
direct support for this hypothesis was found from the
analyses of variance. However, positive correlations be-
tween MMN amplitudes and IDC and Phe levels revealed
that higher IDC scores and Phe levels were associated with
reduced MMN amplitudes, indirectly confirming our
hypothesis that elevated Phe levels would result in smaller
MMN amplitudes. Smaller MMN amplitudes have been
reported to indicate reduced ability to detect stimulus
change and poorer triggering of the frontally mediated
attention switch (Näätänen 1990). Multiple regression
analyses showed that variance in IDC scores accounted
for 52% of the variance in average MMN amplitudes at
frontal sites. Moreover, detailed stepwise regression analy-
ses on lifetime Phe levels showed that individual differ-
ences in Phe level in the first two years of life accounted for
11.6 of the variance in average MMN amplitudes and for
33.3% in high tone MMN amplitudes. These findings are
intriguing and suggest that individual differences in Phe
levels in the first two years of life exert their influence on
frontal brain activity (in this case MMN responses) over a
period of at least 6–12 years. Similar long-lasting relation-
ships between lifetime Phe levels and VEP amplitudes and
latencies were found, but at a later period from 4–6 years.
In the MMN-task, however, there was also a significant
prediction of high tone MMN amplitudes at frontal and
anterior-frontal sites from Phe level at age 8–9 years.
Diffusion tensor imaging (DTI) studies show that white
matter organization continues to develop into adolescence,
although its rate of increase is highest before the age 10
(Ashtari et al. 2007; Giorgio et al. 2008). The prediction of
MMN amplitudes from Phe levels at age 8–9 years might
be indicative of Phe-related infringements of this process of
white matter organization.
In summary, the present study investigated bottom-up
information processing, i.e., triggered by external events, a
fundamental prerequisite for the individual’s responsiveness
to the outside world. Overall, the results confirm the notion
that the quality of dietary control may affect the develop-
ment and maturation of neural circuits, in particular when
passing through critical periods of vulnerability and
opportunity.
The fact that these effects exist over such a long-time
period could indicate that the assumed structural damage
due to early highly elevated Phe levels (Diamond and
Herzberg 1996) may have affected the normal development
of frontal brain functioning in particular. Anderson et al.
(2004) found lifetime Phe levels to be correlated with
severity of white matter abnormalities in children with
PKU, explaining its stronger association with cognitive
performance than concurrent Phe levels. In addition, it has
been suggested that even small reductions in tyrosine, a
precursor of dopamine, has detrimental effects especially on
the dopamine system in pre-frontal brain areas (e.g., dorso-
lateral prefrontal cortex) that may lead to considerable
cognitive deficits (Diamond 2001). Interestingly, there is a
growing body of evidence that children with PKU indeed
have difficulties performing executive function tasks that
are primarily mediated by (pre)frontal brain areas and that
involve, e.g., attentional control, response switching, and
monitoring (Diamond et al. 1997; Huijbregts et al. 2002a;
Leuzzi et al. 2004; Stemerdink et al. 1999; Weglage et al.
1996; Welsh et al. 1990), although it must be noted that
evidence has been presented lately, that does not support
the executive deficit hypothesis (Channon et al. 2004,
2005). The smaller MMN amplitudes found for children
with PKU with higher concurrent and elevated early
lifetime Phe levels could be an indication of frontal
dysfunctions that may underlie executive deficits later in
childhood/adolescence when processing skills call more
strongly upon intact frontal brain areas (Kolb and Fantie
1997; Diamond 2001).
There are limitations to our study. This study is
inevitably about many electrode sites and historical Phe-
levels. Therefore, it was tried to capture possible relation-
ships between Phe-levels and electrocortical indices with
multiple regression analysis, combining sites. Many strong
multiple correlations were found, the majority reaching P-
values <.01. Additionally, one could opt to apply a
Bonferroni correction to adjust for multiple testing, but, in
particular because values on neighboring electrode sites are
known to be correlated, we agree with Perneger (1998)t o
not going this way, but simply describe what we see.
Although our group of patients with PKU was relatively
large, statistical analyses of the many conditions of the task,
as well as partitioning into high Phe (>360 μmol/L) and
low Phe (≤360 μmol/L) subgroups, and the substantial age
range, would have benefited from a larger sample. Also, it
would have been beneficial to a theoretical account of our
results if we had included ERP-measurements during top-
down information processing. Requirement of cognitive
control could have revealed group differences in electro-
cortical measures equivalent to group differences observed
in neuropsychological testing of cognitive control. Finally,
future studies could consider the use of more refined
measures of dietary control when predicting electrocortical
(or neuropsychological) outcomes, such as phe:tyr ratio and
measures of individual phe-level variations across time.
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